The German-Indonesian Society for Medicine (DIGM) places great value on the strategic collaboration and long-term commitment of its Corporate Members. As trusted partners, they play a key role in advancing sustainable medical, scientific and educational cooperation between Germany and Indonesia.
Through their engagement, our Corporate Members actively support the development of innovative initiatives, high-quality professional education and the exchange of expertise across healthcare systems. Their contribution strengthens interdisciplinary collaboration and supports the DIGM’s mission to promote excellence, innovation and responsible progress in medicine and healthcare.
The DIGM sincerely thanks its Corporate Members for their confidence, continued support and shared commitment to building durable, high-impact partnerships that advance international medical collaboration.
About Norgine
Norgineis a medium-sized European specialty pharmaceutical company focused on therapeutic niches. Our unique positioning lies in our ability to fill specific therapeutic gaps. Thanks to our expertise and strong global partner network, we are able to identify promising drug candidates, develop them clinically where necessary, and make them available in our core markets in Europe, Australia and New Zealand. In this way, we make a decisive contribution to therapeutic success and supply our medicines to over 25 million patients worldwide every year.